[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@FiercePharma](/creator/twitter/FiercePharma) "Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph" [X Link](https://x.com/FiercePharma/status/1978915348536869266) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:06Z 99.9K followers, 2482 engagements "ESMO: Results for AZ's Imfinzi in early bladder cancer type suggest it measures up to Pfizer candidate" [X Link](https://x.com/FiercePharma/status/1979285791592317369) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T20:38Z 99.9K followers, 1923 engagements "AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25" [X Link](https://x.com/FiercePharma/status/1979559794106331391) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:46Z 99.9K followers, 2124 engagements "Merck's Keytruda becomes part of the first immune checkpoint inhibitor-based regimen to prove a survival benefit in ovarian cancer #ESMO25" [X Link](https://x.com/FiercePharma/status/1979578145545097318) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T15:59Z 99.9K followers, 2212 engagements "Akeso and Summit Tx's ivonescimab and chemo reduced the risk of progression or death by XX% compared with BeOnes Tevimbra and chemo in Chinese patients with first-line squamous NSCLC according to HARMONi-6 data at #ESMO25" [X Link](https://x.com/FiercePharma/status/1979923542956261408) [@FiercePharma](/creator/x/FiercePharma) 2025-10-19T14:52Z 99.9K followers, 4007 engagements "Pfizer and Astellas' Padcev plus Keytruda delivers 'breakthrough' win in new bladder cancer use" [X Link](https://x.com/FiercePharma/status/1955337237056336244) [@FiercePharma](/creator/x/FiercePharma) 2025-08-12T18:35Z 99.9K followers, 2113 engagements "Biogen told to pay $124M in patent dispute with Genentech" [X Link](https://x.com/FiercePharma/status/1975610321210425731) [@FiercePharma](/creator/x/FiercePharma) 2025-10-07T17:13Z 99.9K followers, 1941 engagements "Pfizer's Lorviqua nabs NICE thumbs up after initial rejection" [X Link](https://x.com/FiercePharma/status/1976303590789743006) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T15:07Z 99.9K followers, 1840 engagements "Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade" [X Link](https://x.com/FiercePharma/status/1976303750621823059) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T15:08Z 99.9K followers, 2307 engagements "AstraZeneca CEO visits White House to formalize MFN agreement with Trump" [X Link](https://x.com/FiercePharma/status/1977790274517586167) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T17:35Z 99.9K followers, 2970 engagements "Novartis advances IgAN efforts with phase X win for Fabhalta plots FDA filing for full approval" [X Link](https://x.com/FiercePharma/status/1978917361747931642) [@FiercePharma](/creator/x/FiercePharma) 2025-10-16T20:14Z 99.9K followers, 2525 engagements "AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25" [X Link](https://x.com/FiercePharma/status/1979557754680529175) [@FiercePharma](/creator/x/FiercePharma) 2025-10-18T14:38Z 99.9K followers, XXX engagements "Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion" [X Link](https://x.com/FiercePharma/status/1976334887058624847) [@FiercePharma](/creator/x/FiercePharma) 2025-10-09T17:12Z 99.9K followers, 2662 engagements "FDA adds warning to label of J&J Legend's Carvykti for potentially fatal intestinal disorder" [X Link](https://x.com/FiercePharma/status/1977793959406739595) [@FiercePharma](/creator/x/FiercePharma) 2025-10-13T17:50Z 99.9K followers, 3038 engagements "Pfizer scores again in HER2-positive breast cancer this time with Seagen's Tukysa" [X Link](https://x.com/FiercePharma/status/1978194095974859024) [@FiercePharma](/creator/x/FiercePharma) 2025-10-14T20:20Z 99.9K followers, 4397 engagements "Merck KGaAs EMD Serono strikes MFN deal in Trump's fertility treatment pricing push" [X Link](https://x.com/FiercePharma/status/1979272497951576295) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:45Z 99.9K followers, 1797 engagements "Sanofi gets one thumbs up one thumbs down from Europe's CHMP" [X Link](https://x.com/FiercePharma/status/1979275472891732235) [@FiercePharma](/creator/x/FiercePharma) 2025-10-17T19:57Z 99.9K followers, 2300 engagements "Merck grows again in Va. with $3B small-molecule drug plant part of planned $70B US outlay" [X Link](https://x.com/FiercePharma/status/1980362234749747400) [@FiercePharma](/creator/x/FiercePharma) 2025-10-20T19:55Z 99.9K followers, 1434 engagements "ESMO: Akeso Summit's ivonescimab beats PD-1 in first chemo combo win in 1st-line NSCLC" [X Link](https://x.com/FiercePharma/status/1980362312352690308) [@FiercePharma](/creator/x/FiercePharma) 2025-10-20T19:55Z 99.9K followers, 1464 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@FiercePharma
"Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph"
X Link @FiercePharma 2025-10-16T20:06Z 99.9K followers, 2482 engagements
"ESMO: Results for AZ's Imfinzi in early bladder cancer type suggest it measures up to Pfizer candidate"
X Link @FiercePharma 2025-10-17T20:38Z 99.9K followers, 1923 engagements
"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"
X Link @FiercePharma 2025-10-18T14:46Z 99.9K followers, 2124 engagements
"Merck's Keytruda becomes part of the first immune checkpoint inhibitor-based regimen to prove a survival benefit in ovarian cancer #ESMO25"
X Link @FiercePharma 2025-10-18T15:59Z 99.9K followers, 2212 engagements
"Akeso and Summit Tx's ivonescimab and chemo reduced the risk of progression or death by XX% compared with BeOnes Tevimbra and chemo in Chinese patients with first-line squamous NSCLC according to HARMONi-6 data at #ESMO25"
X Link @FiercePharma 2025-10-19T14:52Z 99.9K followers, 4007 engagements
"Pfizer and Astellas' Padcev plus Keytruda delivers 'breakthrough' win in new bladder cancer use"
X Link @FiercePharma 2025-08-12T18:35Z 99.9K followers, 2113 engagements
"Biogen told to pay $124M in patent dispute with Genentech"
X Link @FiercePharma 2025-10-07T17:13Z 99.9K followers, 1941 engagements
"Pfizer's Lorviqua nabs NICE thumbs up after initial rejection"
X Link @FiercePharma 2025-10-09T15:07Z 99.9K followers, 1840 engagements
"Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade"
X Link @FiercePharma 2025-10-09T15:08Z 99.9K followers, 2307 engagements
"AstraZeneca CEO visits White House to formalize MFN agreement with Trump"
X Link @FiercePharma 2025-10-13T17:35Z 99.9K followers, 2970 engagements
"Novartis advances IgAN efforts with phase X win for Fabhalta plots FDA filing for full approval"
X Link @FiercePharma 2025-10-16T20:14Z 99.9K followers, 2525 engagements
"AstraZeneca Daiichi unleash Enhertu's 2-fisted power aiming to reshape early breast cancer landscape. #ESMO25"
X Link @FiercePharma 2025-10-18T14:38Z 99.9K followers, XXX engagements
"Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion"
X Link @FiercePharma 2025-10-09T17:12Z 99.9K followers, 2662 engagements
"FDA adds warning to label of J&J Legend's Carvykti for potentially fatal intestinal disorder"
X Link @FiercePharma 2025-10-13T17:50Z 99.9K followers, 3038 engagements
"Pfizer scores again in HER2-positive breast cancer this time with Seagen's Tukysa"
X Link @FiercePharma 2025-10-14T20:20Z 99.9K followers, 4397 engagements
"Merck KGaAs EMD Serono strikes MFN deal in Trump's fertility treatment pricing push"
X Link @FiercePharma 2025-10-17T19:45Z 99.9K followers, 1797 engagements
"Sanofi gets one thumbs up one thumbs down from Europe's CHMP"
X Link @FiercePharma 2025-10-17T19:57Z 99.9K followers, 2300 engagements
"Merck grows again in Va. with $3B small-molecule drug plant part of planned $70B US outlay"
X Link @FiercePharma 2025-10-20T19:55Z 99.9K followers, 1434 engagements
"ESMO: Akeso Summit's ivonescimab beats PD-1 in first chemo combo win in 1st-line NSCLC"
X Link @FiercePharma 2025-10-20T19:55Z 99.9K followers, 1464 engagements
/creator/twitter::18294275/posts